Additive effect of propofol and fentanyl precipitating cardiogenic shock

The intravenous administration of propofol and fentanyl has become a common practice in a variety of clinical settings including outpatient dermatologic, cosmetic and oral surgery. The combination provides both systematic sedation and analgesia with low incidence of unwanted side effects. The cardio...

Descripción completa

Detalles Bibliográficos
Autor principal: Prabhakaran, AC Jesudoss
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746309/
https://www.ncbi.nlm.nih.gov/pubmed/23960431
http://dx.doi.org/10.4103/0976-500X.114612
_version_ 1782280818036572160
author Prabhakaran, AC Jesudoss
author_facet Prabhakaran, AC Jesudoss
author_sort Prabhakaran, AC Jesudoss
collection PubMed
description The intravenous administration of propofol and fentanyl has become a common practice in a variety of clinical settings including outpatient dermatologic, cosmetic and oral surgery. The combination provides both systematic sedation and analgesia with low incidence of unwanted side effects. The cardiogenic shock is very uncommon in healthy individuals. The cardiovascular depressive effect of propofol and fentanyl has been well established, but the development of cardiogenic shock is very rare when these drugs are used together. Hence the awareness of this effect is advantageous to the patients undergoing such surgeries
format Online
Article
Text
id pubmed-3746309
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37463092013-08-19 Additive effect of propofol and fentanyl precipitating cardiogenic shock Prabhakaran, AC Jesudoss J Pharmacol Pharmacother Case Report The intravenous administration of propofol and fentanyl has become a common practice in a variety of clinical settings including outpatient dermatologic, cosmetic and oral surgery. The combination provides both systematic sedation and analgesia with low incidence of unwanted side effects. The cardiogenic shock is very uncommon in healthy individuals. The cardiovascular depressive effect of propofol and fentanyl has been well established, but the development of cardiogenic shock is very rare when these drugs are used together. Hence the awareness of this effect is advantageous to the patients undergoing such surgeries Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3746309/ /pubmed/23960431 http://dx.doi.org/10.4103/0976-500X.114612 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Prabhakaran, AC Jesudoss
Additive effect of propofol and fentanyl precipitating cardiogenic shock
title Additive effect of propofol and fentanyl precipitating cardiogenic shock
title_full Additive effect of propofol and fentanyl precipitating cardiogenic shock
title_fullStr Additive effect of propofol and fentanyl precipitating cardiogenic shock
title_full_unstemmed Additive effect of propofol and fentanyl precipitating cardiogenic shock
title_short Additive effect of propofol and fentanyl precipitating cardiogenic shock
title_sort additive effect of propofol and fentanyl precipitating cardiogenic shock
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746309/
https://www.ncbi.nlm.nih.gov/pubmed/23960431
http://dx.doi.org/10.4103/0976-500X.114612
work_keys_str_mv AT prabhakaranacjesudoss additiveeffectofpropofolandfentanylprecipitatingcardiogenicshock

Ejemplares similares